glycyrrhizic acid has been researched along with Experimental Spinal Cord Ischemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Z; Liu, Y; Ni, B | 1 |
| Ding, L; Liu, B; Ma, Y; Yin, G | 1 |
2 other study(ies) available for glycyrrhizic acid and Experimental Spinal Cord Ischemia
| Article | Year |
|---|---|
Glycyrrhizin protects spinal cord and reduces inflammation in spinal cord ischemia-reperfusion injury.
Topics: Animals; Glycyrrhizic Acid; Inflammation; Inflammation Mediators; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; NF-kappa B; Reperfusion Injury; Spinal Cord Ischemia; Tumor Necrosis Factor-alpha | 2013 |
[Research on the influence of diammonium glycyrrhizinate on the expression of NF-kappaB and neuron apoptosis after spinal cord ischemia-reperfusion injury in rats].
Topics: Animals; Apoptosis; Glycyrrhizic Acid; Male; NF-kappa B; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Spinal Cord; Spinal Cord Ischemia | 2008 |